2nd Annual South Texas Alzheimer’s Conference Public Event
Event Date & TimeFebruary 23, 2020 at 3:00pm-5:30pm
LocationUT Health San Antonio Holly Auditorium, 7703 Floyd Curl Dr., San Antonio, TX 78229
Dedicated to transforming dementia care for patients and their families, the Biggs Institute, in partnership with the Alzheimer's Association, present the South Texas Alzheimer’s Conference Public Event for members of the community to come together for an afternoon of support and discovery surrounding Alzheimer's disease.
At this Free Special Event, Attendees will:
- Talk to leading physicians and researchers about your questions on dementia care and research.
- Be connected to innovative clinical trials and talk to the clinical team members leading the trials.
- Hear the latest discoveries from the region's first brain bank and learn what this research means for the future of dementia care.
- Hear a bilingual panel discussion with world-renowned experts on new therapies being offered all around the world.
- Learn about local resources and social events for individuals with dementia and their caregivers.
Schedule of Events
3:00pm | Welcome and Opening Remarks
3:10pm | Panel Discussion on "New Hope for Treating and Preventing Alzheimer's and Other Dementias: Discoveries from Around the World" Moderated by David Martin Davies from Texas Public Radio's "The Source"
4:30pm | Meet the Experts in Dementia Care Tables and Closing Reception
Registration and parking are free. Handicapped parking and shuttle transportation from the parking lot to the event building will be available.
Registration is required.
Save to CalendarAdd to calendar
About the Speaker(s)
Sudha Seshadri, M.D.
Founding Director of the Glenn Biggs Institute for Alzheimer's and Neurodegenerative Diseases
Dr. Seshadri's research focuses on Alzheimer’s disease, dementia and the genetics of stroke and vascular brain injury.
Mercè Boada, M.D., Ph.D.
Founder and Medical Director of Fundació ACE - Barcelona Alzheimer Treatment & Research Center
Dr. Boada's research focuses on diagnosis, pharmacologic and non-pharmacologic treatment for Alzheimer's and other dementias and basic, social, bioethical and legal research applied to the welfare and protection of people suffering dementia and their caregivers.
Christopher Chen, Ph.D.
Associate Professor at the Departments of Pharmacology and Psychological Medicine at the National University of Singapore
Dr. Chen's research and clinical interests are neuroimaging, molecular biology and treatment of stroke and dementia
Bess Frost, Ph.D.
Assistant Professor at UT Health San Antonio
Dr. Frost's research surrounds the basic neurobiology connecting toxic forms of tau to neuronal death and dysfunction.
Hans Jörgen Grabe, Ph.D.
Chairman of the Department of Psychiatry and Psychotherapy of the University Medicine Greifswald in Germany
Dr. Grabe's research focuses on on the identification of biological and psychosocial risk and protective factors of depressive disorders and neurodegeneration.
Gregory A. Jicha, M.D., Ph.D.
Professor at Sanders-Brown Center on Aging at the University of Kentucky and also serves on the Clinical Task Force and Steering Committee for the National Institute of Aging Alzheimer’s Disease Center Program
Dr. Jicha's current research interests are in the areas of preclinical disease states, mild cognitive impairment, vascular contributions to dementia and clinical trials of disease modifying therapies for degenerative dementias.